Obeldesivir
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Obeldesivir, covering 2024-12-20 to 2026-06-30. Get the full timeline:
Most recent: Clinical Trial Results: Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection [Phase 2]